Aerie Pharmaceutical's Rhopressa lowers eye pressure By: MarketMinute.com Stock News October 11, 2017 at 17:32 PM EDT A preliminary review by the Food and Drug Administration determined that Aerie Pharmaceuticals Inc.'s (Nasdaq: AERI) Rhopressa lowered eye pressure sending the stock price soaring $8.95 to close at $64.30. Related Stocks: Aerie Pharmaceuticals